BLASINGLE-USEVIAL
Approved
Feb 1999
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
8
Data completeness
5/8 — Partial
ACTIMMUNE (interferon gamma-1b) by Amgen is interferon-stimulated genes. First approved in 1999.
Drug data last refreshed 4h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ACTIMMUNE is interferon gamma-1b, a Type 2 interferon that enhances macrophage oxidative metabolism, natural killer cell activation, and expression of Fc receptors and MHC antigens. It is indicated for chronic granulomatous disease (CGD) and severe malignant osteopetrosis (SMO), rare inherited immunological and bone disorders. The drug works through immune stimulation rather than direct correction of the underlying enzymatic defect.
$26MPart D
LOE ApproachingProduct is approaching loss of exclusivity with modest Part D spend ($26M in 2023), indicating a mature niche market with limited team expansion opportunities.
Mechanism of Action
interferon-stimulated genes. The three major groups of interferons (alpha, beta, gamma) have partially overlapping biological activities that include immunoregulation such as increased resistance to microbial pathogens and inhibition of cell proliferation. Type 1 interferons (alpha and beta) bind…
Pharmacologic Class:
Interferon gamma
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on ACTIMMUNE at Amgen? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.